Active — Not RecruitingNot Applicable

Community Smart Aging Model - Resistance Training

China98 participantsStarted 2025-08-01

Plain-language summary

This clinical trial aims to evaluate the effectiveness of a smart community-based resistance training program in older adults aged 60 and older with primary osteoporosis. The main questions it aims to answer are: Does the 32-week smart resistance training improve lumbar spine bone mineral density (BMD)? Does the training improve lower extremity physical function? Researchers will compare the smart resistance training group with a routine health education control group to see if the resistance training effectively improves bone health and physical capabilities. Participants will: Be randomly assigned to either the resistance training group or the health education group. If in the training group: Wear a smart health bracelet and complete 40 to 60 minutes of elastic band resistance training 3 times a week for 32 weeks, with guidance from smart devices and community staff. If in the health education group: Maintain usual daily activities and attend a monthly group health education lecture on osteoporosis. Complete clinical assessments, including bone density scans (DXA), physical performance tests, and questionnaires at the start, at 16 weeks, and at 32 weeks. Enter a 12-month observational follow-up phase after the 32-week intervention to evaluate the long-term sustainability of the outcomes.

Who can participate

Age range

60 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Aged 60 years or older. * Diagnosed with primary osteoporosis via DXA scan (lumbar spine or hip T-score ≤ -2.5, or ≤ -2.0 with a fragility fracture history). * Possess basic smartphone operation skills. Normal basic cognitive ability (MMSE score ≥ 24) and capable of independent walking. * Reside in the designated community without relocation plans within the next year. * Voluntarily sign the informed consent form. Exclusion Criteria: * Diagnosed with secondary osteoporosis. * Recent major medical events (e.g., fractures or hip/spine surgery within the past 3 months) or uncontrolled severe cardiovascular diseases. * Completely unable to operate smart devices due to severe sensory or communication impairments. * Currently participating in similar exercise interventions or clinical trials. * Terminal illness or life expectancy of less than 1 year. * Lack of support or consent from children or guardians.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Lumbar Spine Bone Mineral Density (BMD)

Timeframe: Baseline ，16 weeks ，32 weeks and Follow-up ended (12 months after the 32-week intervention).

Short Physical Performance Battery (SPPB) Score

Timeframe: Baseline, 16 weeks, 32 weeks and Follow-up ended (12 months after the 32-week intervention).

Trial details

NCT IDNCT07506538

SponsorLingshu Sun

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-03-23

View on ClinicalTrials.gov More Primary Osteoporosis trials